Tweet
Glad to be here, it`s an amazing place.
-
-
中国人就是多啊！我就写中文了，爱咋咋地！Comment
-
has the beijing genomics institute received any of the hiseq2000? i have that read it was an enormous purchase.Comment
-
Sorry, with no idea！
We are BIG, you are talking about BGI. Two different research groups.Comment
-
500年前是一家，哈哈！Comment
-
祝大家虎年平安健康快乐吉祥！Comment
-
Big 是基因组所？Comment
-
Beijing Institute of Genomics=BIG=北京基因组研究所Comment
-
大家新年快乐啊，祝大家虎年吉祥，多发文章！Comment
-
BIG & BGI , so confused...Comment
-
-
-
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...Today, 05:17 AM -
Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.07-01-2026, 11:43 AM
-
I’m not a sequencing expert. I’m a purification scientist who uses NGS to evaluate workflows my group develops. With this perspective, we think about the sample first and the NGS workflow second. The sequencer is an exceptionally honest reporter, but it can only report on what you give it, so whether you get clean, interpretable data from an NGS workflow is largely determined before you begin.
Here are nine questions we think about, in roughly the order they matter, before...
Comment